Biotech companies involved in finding a vaccine or therapeutic for Covid-19 have been among the most popular, and volatile, stocks of 2020. Novavax (NASDAQ:NVAX) is no exception. NVAX stock is up near-2,000% in 2020. But that’s down nearly half from where it has been. Source: Ascannio/Shutterstock.com Novavax is one of the companies receiving funds from
0 Comments
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019. John Tlumacki | Boston Globe | Getty Images Check out the companies making headlines in midday trading.  Uber, Lyft — Shares of the ridehailing companies jumped 13.3% and 12.8%, respectively, after early voting projections suggest that Californians
0 Comments
2011 Gain: $32.87 (60%) 2011 Closing price: $87.61 Last year, investors turned away from HMO stocks such as this, fearing the impact of a new health care overhaul rule involving medical-loss ratios. However, Humana showed it was able to manage the new regulation and in October delivered better-than-expected profits and a better-than-expected forecast for 2012.
0 Comments
After Apple (NASDAQ:AAPL) received a boost from the work-at-home trend in its quarter that ended in June, AAPL stock appears to have reverted to form last quarter, with one exception. Source: dennizn / Shutterstock.com The company’s China business, in-line with my previous warnings, sharply contracted, indicating that the hardware giant could have a big, ongoing
0 Comments
It’s been a great year to be involved with gold. For example, the SPDR Gold Shares (NYSEARCA:GLD), is higher by 24.5%. However, it’s an even better time to embrace gold stocks. The VanEck Vectors Gold Miners ETF (NYSEARCA:GDX) proves as much with year-to-date gain of almost 32%. Those data points underscore the double-edged sword that
0 Comments
Roku (NASDAQ:ROKU) stock surged to all-time highs after the streaming device maker reported quarterly figures that absolutely crushed revenue and profit expectations. Source: Fozan Ns / Shutterstock.com Specifically, Roku topped revenue estimates by over 20% — growing revenues by a record-high 73% year-over-year — while reporting a sizable profit in the quarter (Wall Street was
0 Comments
Guggenheim Partner’s Scott Minerd told CNBC that Wednesday’s rally on Wall Street makes sense, despite the uncertain outcome in the presidential race between President Donald Trump and Democrat Joe Biden. “I was always of the opinion, regardless of the outcome, short of getting anarchy in the street, that this would be good for stocks,” the
0 Comments
Take a look at some of the biggest movers in the premarket: CVS Health (CVS) – CVS named Executive Vice President Karen Lynch as its next CEO, effective Feb. 1, replacing the retiring Larry Merlo. Separately, CVS reported better-than-expected sales and profit for its latest quarter, as prescription drug volumes rebounded. Shares rose 2% in
0 Comments
The Trade Desk (NASDAQ:TTD) stock took off like a rocket ship in early November after the programmatic advertising leader reported huge revenue and profit beats in its third-quarter earnings report. Source: shutterstock.com Specifically, The Trade Desk topped revenue estimates by an impressive 20%, while almost tripling consensus earnings estimates. TTD stock soared about 30% to
0 Comments
Warren Buffett Gerard Miller | CNBC As the coronavirus pandemic weighs on its operating earnings and stock price, Berkshire Hathaway ramped up its stock repurchasing program even more in the third quarter, nearly doubling the record buyback from the second quarter. Warren Buffett’s conglomerate bought back $9 billion of its own stock, it was revealed
0 Comments
The labor market was stronger than expected in October, showing good momentum ahead of the latest wave of coronavirus cases. The economy added 638,000 nonfarm payrolls and the unemployment rate fell by a full percentage point to 6.9%. The government compiled the data for the report in the middle of October. Stock futures temporarily erased
0 Comments
Ternium (NYSE:TX) announced its third-quarter earnings results this week and reported a significant bottom-line beat. $0.74 per share was the number reported, which was $0.43 per share north of consensus. The company also beat on the top line as sales came in at $2.14 billion ($113 million ahead of consensus). These numbers really demonstrate how
0 Comments